OppenheimerFunds’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	$59.3M	Buy	47,601 +164	+0.3%	+$204K	0.07%	273
2018 Q4	$44.9M	Buy	47,437 +3,216	+7%	+$3.05M	0.06%	298
2018 Q3	$63.7M	Buy	44,221 +14,609	+49%	+$21M	0.07%	280
2018 Q2	$47.8M	Buy	29,612 +4,563	+18%	+$7.36M	0.06%	337
2018 Q1	$40.7M	Buy	+25,049	New	+$40.7M	0.05%	371